Active smokers are at higher risk of COVID-19 death: a systematic review and meta-analysis
R Patanavanich, T Siripoon… - Nicotine and …, 2023 - academic.oup.com
Introduction Current evidence indicates that smoking worsens COVID-19 outcomes.
However, when studies restricted their analyses to current smokers, the risks for COVID-19 …
However, when studies restricted their analyses to current smokers, the risks for COVID-19 …
[HTML][HTML] Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: should humoral responses be monitored? A position article
J Barrière, M Carles, C Audigier-Valette, D Re… - European Journal of …, 2022 - Elsevier
Taking into account higher risk of severe coronavirus disease 2019 or death among patients
with cancer, as well as impaired immunogenicity after anti-SARS-CoV-2 vaccines, in …
with cancer, as well as impaired immunogenicity after anti-SARS-CoV-2 vaccines, in …
Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer
Importance As the COVID-19 pandemic continues, understanding the clinical outcomes of
patients with cancer and COVID-19 has become critically important. Objective To compare …
patients with cancer and COVID-19 has become critically important. Objective To compare …
Differences in outcomes and factors associated with mortality among patients with SARS-CoV-2 infection and cancer compared with those without cancer: a …
Importance SARS-CoV-2 infection has been associated with more severe disease and
death in patients with cancer. However, the implications of certain tumor types, treatments …
death in patients with cancer. However, the implications of certain tumor types, treatments …
Obesity is associated with severe disease and mortality in patients with coronavirus disease 2019 (COVID-19): a meta-analysis
Z Cai, Y Yang, J Zhang - BMC public health, 2021 - Springer
Background The coronavirus disease 2019 (COVID-19) pandemic has led to global
research to predict those who are at greatest risk of developing severe disease and …
research to predict those who are at greatest risk of developing severe disease and …
[HTML][HTML] Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic …
M Peeters, L Verbruggen, L Teuwen, G Vanhoutte… - ESMO open, 2021 - Elsevier
Background Cancer patients are at a higher risk of developing severe coronavirus disease
2019 (COVID-19). However, the safety and efficacy of COVID-19 vaccination in cancer …
2019 (COVID-19). However, the safety and efficacy of COVID-19 vaccination in cancer …
Humoral immune response in hematooncological patients and health care workers who received SARS-CoV-2 vaccinations
MJ Mair, JM Berger, AS Berghoff, AM Starzer… - JAMA …, 2022 - jamanetwork.com
Importance To our knowledge, little is known about antibody development after SARS-CoV-
2 vaccination in immunocompromised individuals, such as patients with cancer. Objective …
2 vaccination in immunocompromised individuals, such as patients with cancer. Objective …
[HTML][HTML] Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France
JY Blay, S Boucher, B Le Vu, C Cropet, S Chabaud… - ESMO open, 2021 - Elsevier
Background The impact of the first coronavirus disease 2019 (COVID-19) wave on cancer
patient management was measured within the nationwide network of the Unicancer …
patient management was measured within the nationwide network of the Unicancer …
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study …
Summary Background Breakthrough SARS-CoV-2 infections following vaccination against
COVID-19 are of international concern. Patients with cancer have been observed to have …
COVID-19 are of international concern. Patients with cancer have been observed to have …
[HTML][HTML] SARS-CoV-2 vaccines for cancer patients: a call to action
C Corti, E Crimini, P Tarantino, G Pravettoni… - European Journal of …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) has affected more than 96 million people
worldwide, leading the World Health Organization (WHO) to declare a pandemic in March …
worldwide, leading the World Health Organization (WHO) to declare a pandemic in March …